文献速递糖尿病

戒烟及戒烟后体重变化与2型糖尿病患者心血管疾病发病率和死亡率的关系:一项基于人群的队列研究

Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2020-01-07

该研究基于美国护士健康研究(1976-2014)和卫生专业人员随访研究(1986-2014)两个前瞻性队列,纳入10809例2型糖尿病患者分析心血管疾病发病、9688例分析死亡。结果显示近期戒烟且6年内未增重者心血管疾病风险显著低于持续吸烟者(HR 0.77,95%CI 0.62-0.95),远期戒烟者全因死亡风险降低且不受增重影响。结论认为戒烟不增重与心血管疾病和死亡风险降低相关,增重会减弱戒烟对心血管疾病的获益但不减弱对死亡率的获益。

要点

  • 近期戒烟(2-6年)且6年内未增重者心血管疾病风险显著低于持续吸烟者(HR 0.77,95%CI 0.62-0.95)。
  • 远期戒烟(>6年)者全因死亡风险降低,且增重0.1-5.0 kg或>5.0 kg均未减弱该获益。
  • 戒烟后增重会减弱心血管疾病风险降低的获益,但不减弱死亡率的获益。

核心结论

  • 戒烟后未增重与2型糖尿病吸烟者心血管疾病和死亡风险降低相关。
  • 戒烟后增重减弱了心血管疾病发病风险降低的获益,但不减弱戒烟对死亡率的获益。
  • 这些发现确认了2型糖尿病患者戒烟的总体健康获益,同时强调戒烟后体重管理对最大化健康获益的重要性。

研究设计与样本

  • 基于人群的前瞻性队列研究,数据来自美国护士健康研究(1976-2014)和卫生专业人员随访研究(1986-2014)。
  • 总队列173229人(护士健康研究121700人,卫生专业人员随访研究51529人),纳入10809例2型糖尿病患者进行心血管疾病发病分析,9688例进行死亡分析。
  • 纳入在糖尿病诊断时无心血管疾病和癌症的当前吸烟者或从不吸烟者,每2年通过验证问卷更新吸烟状态和体重变化等信息。
  • 采用多变量校正Cox比例风险模型估计戒烟和体重变化与结局关联的风险比(HR)。

主要发现

  • 心血管疾病分析随访153166人年,发生2580例心血管疾病事件;死亡分析随访152811人年,发生3827例死亡。
  • 近期戒烟(戒烟2-6年)且戒烟后6年内未增重者心血管疾病风险显著低于持续吸烟者(多变量校正HR 0.77,95%CI 0.62-0.95);所有近期戒烟者HR 0.83(95%CI 0.70-0.99);增重0.1-5.0 kg者HR 0.99(95%CI 0.70-1.41);增重>5.0 kg者HR 0.89(95%CI 0.65-1.23);远期戒烟(>6年)者HR 0.72(95%CI 0.61-0.84)。
  • 远期戒烟者全因死亡风险降低且不受戒烟后6年内增重影响:未增重者HR 0.69(95%CI 0.58-0.82),增重0.1-5.0 kg者HR 0.57(95%CI 0.45-0.71),增重>5.0 kg者HR 0.51(95%CI 0.42-0.62);心血管疾病死亡和癌症死亡结果相似。

临床怎么用

  • 作者认为,这些发现确认了2型糖尿病患者戒烟的总体健康获益,同时强调戒烟后体重管理对最大化健康获益的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To reduce their overall substantially increased risk of cardiovascular disease and premature mortality, smoking cessation is especially important for people with diabetes. However, the effect of weight change after quitting smoking on the long-term health consequences of smoking cessation is unclear. We aimed to examine smoking cessation and subsequent weight change in relation to incident cardiovascular disease events and mortality among adults with type 2 diabetes. METHODS: In this population-based cohort study, we analysed data from people with type 2 diabetes from two prospective cohorts in the USA: the Nurses' Health Study (1976-2014) and the Health Professionals Follow-Up Study (1986-2014). We included participants from both cohorts who either had prevalent type 2 diabetes or were diagnosed during the study, and who were either current smokers or never smokers without cardiovascular disease or cancer at diagnosis of diabetes. Information on demographics, newly diagnosed diseases, medical history, and lifestyle factors, including smoking status and weight change, was updated every 2 years through validated questionnaires. We assessed the incidence of cardiovascular disease and all-cause and cause-specific mortality among recent quitters (within 6 years of stopping) and long-term quitters (>6 years) associated with weight change within 6 years of smoking cessation among people with type 2 diabetes. We did a multivariable-adjusted Cox proportional hazard models to estimate hazard ratios (HRs) for the associations of smoking cessation and weight change on the outcomes. FINDINGS: Of 173 229 total cohort participants (121 700 from the Nurses' Health Study and 51 529 from the Health Professionals Follow-Up Study), 10 809 people with type 2 diabetes were included in the incident cardiovascular disease analysis and 9688 were included in the mortality analysis. 2580 incident cases of cardiovascular disease occurred during 153 166 person-years of follow-up, and 3827 deaths occurred during 152 811 person-years of follow-up. Recent quitters (2-6 consecutive years since smoking cessation) without weight gain within the first 6 years of quitting had a significantly lower risk of cardiovascular disease than people who continued to smoke (multivariable-adjusted HR 0·83 [95% CI 0·70-0·99] among all recent quitters, 0·77 [0·62-0·95] among recent quitters without weight gain, 0·99 [0·70-1·41] among recent quitters with weight gain of 0·1-5·0 kg, 0·89 [0·65-1·23] among recent quitters with weight gain of >5·0 kg, and 0·72 [0·61-0·84] among longer-term quitters [>6 consecutive years since smoking cessation]). Weight gain within 6 years after smoking cessation did not attenuate the inverse relation between long-term cessation and all-cause mortality (multivariable-adjusted HR 0·69 [95% CI 0·58-0·82] among long-term quitters without weight gain, 0·57 [0·45-0·71] among long-term quitters with weight gain of 0·1-5·0 kg, and 0·51 [0·42-0·62] among long-term quitters with weight gain of >5·0 kg), with similar results observed for cardiovascular disease and cancer mortality. INTERPRETATION: Smoking cessation without subsequent weight gain is associated with a reduced risk of cardiovascular disease and mortality among smokers with type 2 diabetes. Weight gain after smoking cessation attenuates the reduction in risk of developing cardiovascular disease, but does not attenuate the beneficial effect of smoking cessation with respect to mortality. These findings confirm the overall health benefits of quitting smoking among people with type 2 diabetes, but also emphasise the importance of weight management after smoking cessation to maximise its health benefits. FUNDING: US National Institutes of Health.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Liu G, Hu Y, Zong G, et al. Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study. Lancet Diabetes Endocrinol. 2020. PMID: 31924561. doi:10.1016/S2213-8587(19)30413-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。